HK Stock MarketDetailed Quotes

01558 HEC CJ PHARM

Watchlist
  • 9.920
  • -0.220-2.17%
Not Open Aug 30 16:08 CST
8.73BMarket Cap4.83P/E (TTM)

HEC CJ PHARM Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

HEC CJ PHARM H1 FY2024 Earnings Date

Currency：CNYAug 30, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
2.45B
--
-23.50%
EPS
--
0.80
--
-32.30%
Analyst Rating
Strong Buy

Sep 1, 2024

HEC CJ PHARM Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Mar 24, 20232022/H22.452B / 823.000M--
Aug 21, 20192019/H13.071B / ----
DatePeriodRevenue/EstimateEarnings Call
Mar 24, 20232022/H22.452B / 823.000M--
Aug 21, 20192019/H13.071B / ----
--------
--------
--------

Unlock Free Earnings Estimates

HEC CJ PHARM Earnings Reports

  • HEC CJ PHARM: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED 30 JUNE 2024

    Aug 30 08:30 ET

  • HEC CJ PHARM: NOTICE OF BOARD MEETING

    Aug 20 05:22 ET

  • HEC CJ PHARM: SUPPLEMENTAL ANNOUNCEMENT IN RELATION TOANNUAL REPORT 2023

    Jun 7 10:40 ET

  • HEC CJ PHARM: JOINT ANNOUNCEMENT (1) PROPOSED PRE-CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. BY SUNSHINE LAKE PHARMA CO., LTD. BY WAY OF MERGER BY ABSORPTION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. (2) PROPOSED SPECIAL DIVIDE

    May 10 09:28 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 1, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    HK
    Overall
    Symbol
    Latest Price
    % Chg